» Articles » PMID: 36011168

Artificial Intelligence Applied to Pancreatic Imaging: A Narrative Review

Overview
Specialty Health Services
Date 2022 Aug 26
PMID 36011168
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnosis, evaluation, and treatment planning of pancreatic pathologies usually require the combined use of different imaging modalities, mainly, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). Artificial intelligence (AI) has the potential to transform the clinical practice of medical imaging and has been applied to various radiological techniques for different purposes, such as segmentation, lesion detection, characterization, risk stratification, or prediction of response to treatments. The aim of the present narrative review is to assess the available literature on the role of AI applied to pancreatic imaging. Up to now, the use of computer-aided diagnosis (CAD) and radiomics in pancreatic imaging has proven to be useful for both non-oncological and oncological purposes and represents a promising tool for personalized approaches to patients. Although great developments have occurred in recent years, it is important to address the obstacles that still need to be overcome before these technologies can be implemented into our clinical routine, mainly considering the heterogeneity among studies.

Citing Articles

Pancreatic cancer: Future challenges and new perspectives for an early diagnosis.

Cocca S, Pontillo G, Lupo M, Lieto R, Marocchi M, Marsico M World J Clin Oncol. 2025; 16(2):97248.

PMID: 39995556 PMC: 11686566. DOI: 10.5306/wjco.v16.i2.97248.


Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery.

Soreide K, Ismail W, Roalso M, Ghotbi J, Zaharia C Cancer Control. 2023; 30:10732748231154711.

PMID: 36916724 PMC: 9893084. DOI: 10.1177/10732748231154711.


Enhanced Patient-Centricity: How the Biopharmaceutical Industry Is Optimizing Patient Care through AI/ML/DL.

Zou K, Li J Healthcare (Basel). 2022; 10(10).

PMID: 36292444 PMC: 9602573. DOI: 10.3390/healthcare10101997.

References
1.
Frokjaer J, Lisitskaya M, Jorgensen A, Ostergaard L, Hansen T, Drewes A . Pancreatic magnetic resonance imaging texture analysis in chronic pancreatitis: a feasibility and validation study. Abdom Radiol (NY). 2020; 45(5):1497-1506. DOI: 10.1007/s00261-020-02512-8. View

2.
Lin Q, Ji Y, Chen Y, Sun H, Yang D, Chen A . Radiomics model of contrast-enhanced MRI for early prediction of acute pancreatitis severity. J Magn Reson Imaging. 2019; 51(2):397-406. DOI: 10.1002/jmri.26798. View

3.
Gibson E, Giganti F, Hu Y, Bonmati E, Bandula S, Gurusamy K . Automatic Multi-Organ Segmentation on Abdominal CT With Dense V-Networks. IEEE Trans Med Imaging. 2018; 37(8):1822-1834. PMC: 6076994. DOI: 10.1109/TMI.2018.2806309. View

4.
Xie T, Wang X, Li M, Tong T, Yu X, Zhou Z . Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection. Eur Radiol. 2020; 30(5):2513-2524. DOI: 10.1007/s00330-019-06600-2. View

5.
Wei R, Lin K, Yan W, Guo Y, Wang Y, Li J . Computer-Aided Diagnosis of Pancreas Serous Cystic Neoplasms: A Radiomics Method on Preoperative MDCT Images. Technol Cancer Res Treat. 2019; 18:1533033818824339. PMC: 6374001. DOI: 10.1177/1533033818824339. View